Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Banco de datos
Idioma
Tipo del documento
Publication year range
1.
Vopr Med Khim ; 27(2): 247-51, 1981.
Artículo en Ruso | MEDLINE | ID: mdl-7281565

RESUMEN

L-DOPA, which is a metabolic precursor of catecholamines, reduced the manifestations of hyperlipidemia developed in animals after administration of Triton WR-1339, dexametasone or cholesterol. At the same time, L-DOPA decreased the rate of lipolysis, induced by adrenaline injection, as well as the content of 11-hydrocorticosteroids in blood plasma.


Asunto(s)
Levodopa/farmacología , Metabolismo de los Lípidos , Animales , Colesterol/farmacología , Detergentes/farmacología , Dexametasona/farmacología , Epinefrina/farmacología , Cobayas , Hiperlipidemias/metabolismo , Movilización Lipídica/efectos de los fármacos , Masculino , Ratones , Polietilenglicoles/farmacología , Ratas
4.
Biull Eksp Biol Med ; 81(5): 558-9, 1976 May.
Artículo en Ruso | MEDLINE | ID: mdl-947379

RESUMEN

Experiments on rabbits which received cholesterol in food for 3-4 months showed an inhibitory effect of ethirazol (bis-methylamide-1-ethyl-pyrazol-3,4-bicarbonic acid) and parmidine (piridinolcarbamate, 2,6-bis-hydroxymethylpiridine bis-n-methylcarbamate) on the development of experimental atherosclerosis: there proved to be a reduction of accumulation of total cholesterol in the aorta and of its atherosclerotic affection. At the same time the blood serum cholesterol, triglycerids and phospholipid content was not significantly changed by these drugs.


Asunto(s)
Arteriosclerosis/prevención & control , Carbamatos/uso terapéutico , Pirazoles/uso terapéutico , Piridinolcarbamato/uso terapéutico , Animales , Anticolesterolemiantes/uso terapéutico , Dieta Aterogénica , Masculino , Conejos
5.
Biull Eksp Biol Med ; 83(3): 289-91, 1977 Mar.
Artículo en Ruso | MEDLINE | ID: mdl-558018

RESUMEN

Chronic irritation of the falsely operated rats and those with the deafferentated hypothalamus led to reduction of total blood cholesterol and the accumulation of triglycerides in the liver. Dexamethasone administration was accompanied by an increase of blood cholesterol and triglycerides and the triglyceride accumulation in the liver. The action of dexamethasone was more pronounced in the animals with the deafferentated hypothalamus. The rate of 11-oxycorticosteroid secretion into the adrenal vein is reduced in the latter.


Asunto(s)
11-Hidroxicorticoesteroides/metabolismo , Corteza Suprarrenal/metabolismo , Glándulas Suprarrenales/metabolismo , Dexametasona/farmacología , Hipotálamo/fisiología , Metabolismo de los Lípidos , Estrés Psicológico/fisiología , Animales , Colesterol/metabolismo , Humanos , Inmovilización , Hígado/metabolismo , Masculino , Neuronas Aferentes/fisiología , Ratas , Triglicéridos/metabolismo
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda